NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Prospective Blinded Evaluation of Ur24 Technology’s revolutionary active external catheter system found it to be “highly effective” at removing urine from the ...
WAYNE, Pa. & TULLINGE, Sweden--(BUSINESS WIRE)--XyloCor Therapeutics, Inc. (“XyloCor”), a clinical‑stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, and ...
Only a few months after Medtronic completed its acquisition of cardiac device maker Affera, the nearly billion-dollar buyout is already paying off. A dual-use catheter originally developed by Affera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback